Literature DB >> 25583167

Human Influenza A Virus-Specific CD8+ T-Cell Response Is Long-lived.

Carolien E van de Sandt1, Marine L B Hillaire1, Martina M Geelhoed-Mieras1, Albert D M E Osterhaus2, Ron A M Fouchier1, Guus F Rimmelzwaan2.   

Abstract

Animal and human studies have demonstrated the importance of influenza A virus (IAV)-specific CD8(+) cytotoxic T lymphocytes (CTLs) in heterosubtypic cross-protective immunity. Using peripheral blood mononuclear cells obtained intermittently from healthy HLA-typed blood donors between 1999 and 2012, we were able to demonstrate that IAV-specific CTLs are long-lived. Intercurrent IAV infections transiently increase the frequency of functionally distinct subsets of IAV-specific CTLs, in particular effector and effector memory T cells.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD8+ T cells; human; immunity; influenza A virus; longevity

Mesh：

Year:  2015        PMID： 25583167      PMCID： PMC4542594          DOI： 10.1093/infdis/jiv018

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  15 in total

1.  Early establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cells.

Authors:  Katherine Kedzierska; Vanessa Venturi; Kenneth Field; Miles P Davenport; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 2.  T cells and viral persistence: lessons from diverse infections.

Authors:  Paul Klenerman; Ann Hill
Journal:  Nat Immunol       Date:  2005-09       Impact factor: 25.606

3.  Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.

Authors:  Rogier Bodewes; Pieter L A Fraaij; Martina M Geelhoed-Mieras; Carel A van Baalen; Harm A W M Tiddens; Annemarie M C van Rossum; Fiona R van der Klis; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Authors:  R Bodewes; G de Mutsert; F R M van der Klis; M Ventresca; S Wilks; D J Smith; M Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

Review 5.  Influenza virus: a master of metamorphosis.

Authors:  J C De Jong; G F Rimmelzwaan; R A Fouchier; A D Osterhaus
Journal:  J Infect       Date:  2000-05       Impact factor: 6.072

6.  Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Gerrie de Mutsert; Martina M Geelhoed-Mieras; Marine L B Hillaire; Stella E Vogelzang-van Trierum; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 7.  Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines.

Authors:  Rafi Ahmed; Rama S Akondy
Journal:  Immunol Cell Biol       Date:  2011-02-08       Impact factor: 5.126

8.  Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.

Authors:  K J Flynn; G T Belz; J D Altman; R Ahmed; D L Woodland; P C Doherty
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

9.  Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

Authors:  Björn F Koel; David F Burke; Theo M Bestebroer; Stefan van der Vliet; Gerben C M Zondag; Gaby Vervaet; Eugene Skepner; Nicola S Lewis; Monique I J Spronken; Colin A Russell; Mikhail Y Eropkin; Aeron C Hurt; Ian G Barr; Jan C de Jong; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

10.  Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.

Authors:  A L Frank; J Puck; B J Hughes; T R Cate
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948
View more
  29 in total

1.  SIMON, an Automated Machine Learning System, Reveals Immune Signatures of Influenza Vaccine Responses.

Authors:  Adriana Tomic; Ivan Tomic; Yael Rosenberg-Hasson; Cornelia L Dekker; Holden T Maecker; Mark M Davis
Journal:  J Immunol       Date:  2019-06-14       Impact factor: 5.422

Review 2.  Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.

Authors:  Annette Fox; Kylie M Quinn; Kanta Subbarao
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

3.  The cellular and humoral immune response to influenza vaccination is comparable in asthmatic and healthy subjects.

Authors:  Andrea Aida Velasco-Medina; Miguel Leonardo García-León; Guillermo Velázquez-Sámano; Rosa María Wong-Chew
Journal:  Hum Vaccin Immunother       Date:  2020-05-21       Impact factor: 3.452

Review 4.  Innate and adaptive T cells in influenza disease.

Authors:  Simone Nüssing; Sneha Sant; Marios Koutsakos; Kanta Subbarao; Thi H O Nguyen; Katherine Kedzierska
Journal:  Front Med       Date:  2018-01-20       Impact factor: 9.927

Review 5.  Development of cross-protective influenza a vaccines based on cellular responses.

Authors:  Peter Christiaan Soema; Elly van Riet; Gideon Kersten; Jean-Pierre Amorij
Journal:  Front Immunol       Date:  2015-05-15       Impact factor: 7.561

6.  Mathematical Model Reveals the Role of Memory CD8 T Cell Populations in Recall Responses to Influenza.

Authors:  Veronika I Zarnitsyna; Andreas Handel; Sean R McMaster; Sarah L Hayward; Jacob E Kohlmeier; Rustom Antia
Journal:  Front Immunol       Date:  2016-05-09       Impact factor: 7.561

Review 7.  Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.

Authors:  Saranya Sridhar
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

8.  Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines.

Authors:  Rahul Subramanian; Andrea L Graham; Bryan T Grenfell; Nimalan Arinaminpathy
Journal:  PLoS Comput Biol       Date:  2016-12-15       Impact factor: 4.475

Review 9.  Immune responses after live attenuated influenza vaccination.

Authors:  Kristin G-I Mohn; Ingrid Smith; Haakon Sjursen; Rebecca Jane Cox
Journal:  Hum Vaccin Immunother       Date:  2018-01-03       Impact factor: 3.452

Review 10.  The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?

Authors:  Brian J Ward; Stephane Pillet; Nathalie Charland; Sonia Trepanier; Julie Couillard; Nathalie Landry
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.